Industry Outlook and Trend Analysis
The Transcatheter Embolization and Occlusion Devices Market was worth USD 2.34 billion in 2014 and is expected to reach approximately USD 5.29 billion by 2023, while registering itself at a compound annual growth rate (CAGR) of 9.50% during the forecast period. The market is observing significant development in the course of the most recent decade. The change in perspective from clipping to coiling has invigorated the interest for transcatheter embolization devices. Rising demand of embolization strategies in the treatment of cancer is basically boosting the TEO market development. Minimally invasive surgery is another main consideration decidedly affecting the worldwide business. Commercially accessible embolization products, for example, fluid embolic and embolization particles bolster minimally invasive surgeries. Minimally invasive surgeries lessen recuperating time and surgical injuries.
Product Outlook and Trend Analysis
Coils and non-coils are the two kinds of embolization gadgets financially accessible. Coiling being one of the oldest methods is generally embraced by healthcare professionals comprehensively. In addition, accessibility of a wide scope of coils in different shapes and sizes additionally makes the system more positive for various cases. Pushable coils represented the biggest share of around 56% of every 2014 inferable from high awareness with respect to the product. Nonetheless, disadvantages related with pushable coils , for example, the likelihood of being trapped in sharp curves of the veins, trouble in repositioning once sent, and plausibility of getting stuck in catheters are seen to hinder its selection.
Regional Outlook and Trend Analysis
North America and Europe together represented the largest share of the overall industry of around 58% in 2014. The existence of well-defined regulatory framework, propelled social insurance framework, and experienced medicinal services experts to play out the strategies are a portion of the elements encountered to fuel interest for TEO in these areas. Asia Pacific is foreseen to develop at the speediest CAGR amid the estimate time frame.
The leading players in the market are St. Jude Medical, DePuy Synthes Companies, Medtronic, Cook Group, Stryker Corporation, Terumo Corporation, Cordis Corporation, Sirtex Medical and Boston Scientific. The major players in the market are profiled in detail in view of qualities, for example, company portfolio, business strategies, financial overview, recent developments, and share of the overall industry.
The Transcatheter Embolization and Occlusion Devices Market is segmented as follows-
Flow Diverting Devices
Other Embolization and Occlusion Devices
Rest of Europe
Rest of Asia Pacific
Rest of the World
United Arab Emirates
Some of the key questions answered by the report are:
What was the market size in 2014 and forecast from 2015 to 2023?
What will be the industry market growth from 2015 to 2023?
What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast?
What are the major segments leading the market growth and why?
Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition?